González-Gómez I, Ruíz-Carrascoso G, Herruzo-Cabrera R
Autonomous University of Madrid, Madrid, Spain.
Clinical Microbiology Department, Universitary Hospital of La Paz, Madrid, Spain.
Infect Prev Pract. 2025 Jul 3;7(3):100469. doi: 10.1016/j.infpip.2025.100469. eCollection 2025 Sep.
Carbapenemase-producing Enterobacterales (CPE) are a growing issue that healthcare systems all over the world are facing and which have been producing clinical cases for >20 years, with a spike in incidence in the last decade. In the Universitary Hospital of La Paz (HULP), the first CPE outbreak occurred in 2011 and incidence has been variable since then.
To conduct an epidemiological analysis of the distribution and microbiological characteristics of the four main types of carbapenemases (OXA-48, VIM, KPC, and NDM) obtained from bacteria isolated in the HULP, a tertiary hospital north of the city of Madrid, between 2012 and 2022.
An observational retrospective analysis was performed to attain the incidence characteristics of CPE and their associated outbreaks. The study used data from 5723 individual cases for which the sex and age of the patient, type of sample, isolated bacteria, type of carbapenemase, type of case (infection or colonization) and where and when the isolate was obtained.
Since the first outbreak of CPE was detected in 2011, contain-and-response protocols were put in place to avoid the spread of CPE within the hospital setting.
The implementation of CPE infection preventention and control guidance since 2013 and (in 2022) updated protocols has impacted the number of cases, but further incidence studies should be conducted to analyse the effectiveness of these measures and assess the patterns of carbapenemase genes over time.
产碳青霉烯酶肠杆菌科细菌(CPE)是全球医疗系统面临的一个日益严重的问题,20多年来一直在引发临床病例,在过去十年中发病率激增。在拉巴斯大学医院(HULP),2011年首次发生CPE疫情,此后发病率一直波动不定。
对2012年至2022年期间从马德里市北部一家三级医院HULP分离出的细菌中获得的四种主要类型的碳青霉烯酶(OXA-48、VIM、KPC和NDM)的分布和微生物学特征进行流行病学分析。
进行观察性回顾性分析,以了解CPE的发病特征及其相关疫情。该研究使用了5723例个体病例的数据,包括患者的性别和年龄、样本类型、分离出的细菌、碳青霉烯酶类型、病例类型(感染或定植)以及分离株的获取地点和时间。
自2011年首次检测到CPE疫情以来,已制定 containment-and-response 协议以避免CPE在医院环境中传播。
自2013年以来实施的CPE感染预防和控制指南以及(2022年)更新的协议对病例数量产生了影响,但应进一步开展发病率研究,以分析这些措施的有效性,并评估碳青霉烯酶基因随时间的变化模式。